The mission of the Drug Designing Open Access journal is to provide a forum for publishing new findings on Drug Designing. Currently our primary research objective is to encourage and assist the development of better and faster measures of Drug Designing activities. In cases where we believe we can contribute directly, we are producing our own measures of Drug Designing research. Our work is mainly of interest to investors, organizations and individuals in the financial sector and to significant corporations with global operations, as well as governments and academic researchers. Drug Designing play a key role in the knowledge societies and this knowledge is raising by leaps and bounds within no time. Scientists and academicians require a broad understanding of the latest updates in the respective disciplines for their professional and learning endeavors. PrimeOA Publications International with its open access journals represents the research findings and advancements in various scientific and medical disciplines. Drug Designing journal is focused on the analysis, insight and data relating to questions of importance in understanding the Drug Designing.